Angiodynamics, Inc.
Clinical trials sponsored by Angiodynamics, Inc., explained in plain language.
-
New suction device could save hearts from deadly infection
Disease control Not yet recruitingThis study tests a device called AngioVac that suctions out infected growths (vegetations) from the right side of the heart in people with a serious heart infection called infective endocarditis. The goal is to see if the procedure is safe and helps patients survive without needi…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
New device aims to save legs from amputation in circulation crisis
Disease control Not yet recruitingThis study tests whether using a special device (Auryon Atherectomy System) along with standard balloon angioplasty is safer and more effective than balloon angioplasty alone for clearing blockages in the lower leg arteries. The trial will enroll 50 people with severe peripheral …
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
Electric pulses zap liver cancer in groundbreaking trial
Disease control Not yet recruitingThis study tests a procedure called irreversible electroporation (IRE) to treat liver cancer that hasn't spread. IRE uses short electric pulses to destroy tumor cells without cutting or heating the liver. The study will enroll 50 adults with preserved liver function and up to 3 s…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Electric pulses zapping liver tumors: a new hope for colorectal cancer patients?
Disease control Not yet recruitingThis study tests a procedure called irreversible electroporation (IRE) that uses electric pulses to destroy liver tumors that have spread from colorectal cancer. About 50 adults who have already had at least one round of chemotherapy will receive IRE. The main goal is to see if t…
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated May 17, 2026 11:34 UTC